Table 3.87.
Key considerations for dental management in immunosuppressive treatment (see text)
| Management modifications* | Comments/possible complications | |
|---|---|---|
| Risk assessment | 3 | Oral and extraoral infections |
| Appropriate dental care | 3/4 | Consider antimicrobial prophylaxis and steroid cover |
| Pain and anxiety control | ||
| – Local anaesthesia | 1 | Chlorhexidine rinse |
| – Conscious sedation | 1 | Respiratory function |
| – General anaesthesia | 3/4 | |
| Patient access and positioning | ||
| – Access to dental office | 0 | |
| – Timing of treatment | 0 | |
| – Patient positioning | 0 | |
| Treatment modification | ||
| – Oral surgery | 3/4 | Chlorhexidine; antibiotic cover |
| – Implantology | 3/4 | |
| – Conservative/Endodontics | 2 | |
| – Fixed prosthetics | 2 | |
| – Removable prosthetics | 2 | |
| – Non-surgical periodontology | 3/4 | Chlorhexidine; antibiotic cover |
| – Surgical periodontology | 3/4 | |
| Hazardous and contraindicated drugs | 2 | Avoid drugs which may increase the immunosuppressive agents' levels/toxicity |
0 = No special considerations. 1 = Caution advised. 2 = Specialised medical advice recommended in some cases. 3 = Specialised medical advice mandatory. 4 = Only to be performed in hospital environment. 5 = Should be avoided.